NEFL and amyotrophic lateral sclerosis: NfL, a well-established fluid biomarker in clinical ALS, is a key axonal protein that correlates strongly with ongoing neurodegeneration when measured in plasma or cerebrospinal fluid (CSF) (26, 27).